Vermilion Therapeutics Inc. has been established as new start-up venture. We will work on a discovery for new drug and modality for intractable diseases. Innovative molecules, researched by Professor Kanai and Professor Tomita of the University of Tokyo Graduate School of Pharmaceutical Sciences, are our base technology, that need to be into new medical treatment.